Cryomarex Rispens vakcina A.U.V.
Cryomarex Rispens vakcina A.U.V.
Not authorised
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Product identification
Medicine name:
Cryomarex Rispens vakcina A.U.V.
Active substance:
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
-
Chicken (hen)
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live1000.00/plaque forming unit1.00unit(s)/dose
Pharmaceutical form:
-
Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Chicken (hen)
-
Meat and offal0day
-
-
-
Subcutaneous use
-
Chicken (hen)
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Hungary
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
